CVS Health ( (CVS) ) has provided an announcement.

CVS Health has appointed David Joyner as the new President and CEO, succeeding Karen Lynch, who stepped down from her position. Joyner, who has extensive experience in healthcare and pharmacy benefits, brings a deep understanding of the company’s integrated business model. The company also announced preliminary third-quarter 2024 financial results, highlighting anticipated earnings per share. CVS Health aims to continue improving health outcomes while navigating industry challenges under Joyner’s leadership.

For detailed information about CVS stock, go to TipRanks’ Stock Analysis page.